![](/img/cover-not-exists.png)
428PInterim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors
Bauer, T M, Barve, M, Chiorean, E G, Lorusso, P, Courtney, K, Qi, D, Olguin, A, Bullington, J, Sardone, M, Dunn, V, Shemesh, S, Chen, J, Brooks, C, Wang, JVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.415
Date:
October, 2018
File:
PDF, 76 KB
2018